Research published in Neurology shows that people with Parkinson’s disease who stay physically active experience slower declines in memory and movement.
A small pilot study from UCSF finds that psilocybin significantly lowers inflammatory markers in Parkinson’s patients, hinting at broader anti-inflammatory benefits.
